Related Experiment Video
Updated: Nov 12, 2025
05:19
Using Neuron Spiking Activity to Trigger Closed-Loop Stimuli in Neurophysiological Experiments
Published on: November 12, 2019
7.3K
New Ethical and Clinical Challenges in "Closed-Loop" Neuromodulation.
Manu Hegde1, Winston Chiong2, Vikram R Rao2
1From the Department of Neurology and Weill Institute for Neurosciences, University of California, CA. manu.hegde@ucsf.edu.
Neurology
|March 17, 2021
Summary
Responsive Neurostimulation (RNS) offers a new epilepsy treatment, but presents ethical and clinical challenges. Understanding these issues is crucial for advancing closed-loop neuromodulation in neuropsychiatric disorders.
Area of Science:
- Neurology
- Neurotechnology
- Biomedical Engineering
Background:
- Responsive Neurostimulation (RNS) System by NeuroPace, Inc. offers a novel approach for drug-resistant epilepsy.
- This closed-loop device continuously monitors brain activity and delivers targeted stimulation to reduce seizure frequency.
Observation:
- The chronic implantation of RNS systems provides valuable electrographic data for epilepsy research and treatment.
- Clinical experience reveals significant ethical and clinical dilemmas associated with RNS system use.
Findings:
- Dilemmas identified include electroclinical dissociation, patient concerns regarding device capabilities, clinician burdens, and issues of data ownership and access.
- These challenges highlight the complexities of integrating advanced neurotechnology into patient care.
Implications:
- A framework for addressing these ethical and clinical challenges is essential for the expanding application of closed-loop neuromodulation.
- These insights are transferable to other neurotechnologies targeting various neuropsychiatric disorders.
